DE60222515T2 - BenzoÄbÜpyranoÄ3,2-hÜacridin-7-on Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen - Google Patents

BenzoÄbÜpyranoÄ3,2-hÜacridin-7-on Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen Download PDF

Info

Publication number
DE60222515T2
DE60222515T2 DE60222515T DE60222515T DE60222515T2 DE 60222515 T2 DE60222515 T2 DE 60222515T2 DE 60222515 T DE60222515 T DE 60222515T DE 60222515 T DE60222515 T DE 60222515T DE 60222515 T2 DE60222515 T2 DE 60222515T2
Authority
DE
Germany
Prior art keywords
formula
compounds
chain
branched
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60222515T
Other languages
German (de)
English (en)
Other versions
DE60222515D1 (de
Inventor
Michel Koch
Francois Tillequin
Sylvie Michel
Elisabeth Seguin
Abdelhakim El Omri
John Hickman
Alain Pierre
Bruno Pfeiffer
Pierre Renard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of DE60222515D1 publication Critical patent/DE60222515D1/de
Application granted granted Critical
Publication of DE60222515T2 publication Critical patent/DE60222515T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60222515T 2001-07-25 2002-07-24 BenzoÄbÜpyranoÄ3,2-hÜacridin-7-on Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen Expired - Lifetime DE60222515T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0109910 2001-07-25
FR0109910A FR2827864B1 (fr) 2001-07-25 2001-07-25 Nouveaux derives de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE60222515D1 DE60222515D1 (de) 2007-10-31
DE60222515T2 true DE60222515T2 (de) 2008-07-03

Family

ID=8865868

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222515T Expired - Lifetime DE60222515T2 (de) 2001-07-25 2002-07-24 BenzoÄbÜpyranoÄ3,2-hÜacridin-7-on Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Country Status (24)

Country Link
US (1) US6642248B2 (https=)
EP (1) EP1297835B1 (https=)
JP (1) JP2003055381A (https=)
KR (1) KR100498868B1 (https=)
CN (1) CN1231484C (https=)
AR (1) AR036346A1 (https=)
AT (1) ATE373478T1 (https=)
AU (1) AU2002300268B2 (https=)
BR (1) BR0202864A (https=)
CA (1) CA2395652C (https=)
DE (1) DE60222515T2 (https=)
DK (1) DK1297835T3 (https=)
EA (1) EA005374B1 (https=)
ES (1) ES2294090T3 (https=)
FR (1) FR2827864B1 (https=)
HK (1) HK1053646B (https=)
HU (1) HUP0202485A3 (https=)
MX (1) MXPA02006914A (https=)
NO (1) NO20023556L (https=)
NZ (1) NZ520377A (https=)
PL (1) PL355188A1 (https=)
PT (1) PT1297835E (https=)
SI (1) SI1297835T1 (https=)
ZA (1) ZA200205961B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856687B1 (fr) * 2003-06-25 2005-09-16 Servier Lab Nouveaux derives de benzo[a]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865734B1 (fr) * 2004-02-03 2006-05-19 Servier Lab NOUVAEUX DERIVES DE BENZO[b]CHROMENO-NAPHTHYRIDIN-7-ONE ET DE PYRANO[2'3':7,8]QUINO[2,3-b]QUINOXALIN-7-ONE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
FR2879600B1 (fr) * 2004-12-22 2007-02-09 Servier Lab Nouveaux derives cinnamates de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN107068881B (zh) * 2016-04-25 2019-12-03 中节能万润股份有限公司 一种含有吖啶酮类化合物的有机电致发光器件及其应用
CN115594592B (zh) * 2021-06-28 2024-03-19 江西天宇化工有限公司 一种2-氯-3-硝基苯甲酸的制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224169D0 (en) * 1992-11-18 1993-01-06 Lilly Industries Ltd Pharmaceutical compounds
HRP960352A2 (en) * 1996-07-26 1998-08-31 Pliva Pharm & Chem Works Novel coumarin quinoline carboxylic acids
FR2772765B1 (fr) * 1997-12-19 2000-03-17 Adir Nouveaux derives de l'acronycine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2795071B1 (fr) * 1999-06-16 2001-07-27 Adir Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PT1297835E (pt) 2007-10-19
DK1297835T3 (da) 2008-01-28
CN1398863A (zh) 2003-02-26
PL355188A1 (en) 2003-01-27
EA200200712A1 (ru) 2003-02-27
BR0202864A (pt) 2003-06-03
EP1297835B1 (fr) 2007-09-19
FR2827864B1 (fr) 2005-09-16
HK1053646B (zh) 2006-04-21
CA2395652C (fr) 2008-12-30
DE60222515D1 (de) 2007-10-31
FR2827864A1 (fr) 2003-01-31
CN1231484C (zh) 2005-12-14
HK1053646A1 (en) 2003-10-31
NO20023556L (no) 2003-01-27
ES2294090T3 (es) 2008-04-01
HUP0202485A2 (hu) 2003-04-28
HUP0202485A3 (en) 2005-07-28
SI1297835T1 (sl) 2007-12-31
CA2395652A1 (fr) 2003-01-25
HU0202485D0 (https=) 2002-09-28
AR036346A1 (es) 2004-09-01
ZA200205961B (en) 2003-04-01
EP1297835A1 (fr) 2003-04-02
US6642248B2 (en) 2003-11-04
AU2002300268B2 (en) 2008-05-22
JP2003055381A (ja) 2003-02-26
MXPA02006914A (es) 2005-07-25
KR20030010513A (ko) 2003-02-05
NO20023556D0 (no) 2002-07-25
US20030073841A1 (en) 2003-04-17
NZ520377A (en) 2004-03-26
EA005374B1 (ru) 2005-02-24
KR100498868B1 (ko) 2005-07-04
ATE373478T1 (de) 2007-10-15

Similar Documents

Publication Publication Date Title
DE69635560T2 (de) Camptothecinanaloge, Verfahren zur ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen
DE69728152T2 (de) Hoch-lipophile campothecin-derivate
DE3852288T2 (de) K-252-Derivate mit Antitumorwirkung und diese enthaltende Arzneimittel.
DE69331228T2 (de) Heilmittel für thrombozytopenia
DE60128003T2 (de) Camptothecin derivate
DE69726007T2 (de) Prodrogs und analoga von camptothecin und deren verwendung als arzneimittel
DE69832276T2 (de) Medikamentvorstufen der ribonukleotidreduktase-inhibitoren 3-ap und 3-amp
DE2923368A1 (de) Neue 5-fluor-( beta -uridin oder 2'-desoxy- beta -uridin)-derivate, verfahren zur herstellung derselben und carcinostatische mittel mit einem gehalt derselben
DE19547958B4 (de) Anthracyclin-Derivate
DD294947A5 (de) Verfahren zur herstellung von acylierten epipodophyllotoxinderivaten
DE60002142T2 (de) 12,13-(pyranosyl)-indolo(2,3-a)pyrrolo(3,4-c)carbazol- und 12,13-(pyranosyl)-furo(3,4-c)indolo(2,3-a)carbazol- Derivate, ihr Verfahren zur Herstellung und pharmazeutische Zusammensetzungen, diese enthaltend
DE60222515T2 (de) BenzoÄbÜpyranoÄ3,2-hÜacridin-7-on Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE69806189T2 (de) Acronycinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
AT392793B (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
EP0697405B1 (de) Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE60012287T2 (de) 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphto[2,3-d][1,3]dioxol-6(5aH)-on - Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE112012004569T5 (de) Amorphe Form von Cabazitaxel und Verfahren zum Herstellen davon
DE60012750T2 (de) Neue xanthon derivate, deren herstellung und verwendung als arzneimittel
US4853467A (en) Nitrogen containing derivatives of epipodophyllotoxin glucosides
EP0304086B1 (en) 4'-deshydroxyepipodophyllotoxin glucosides and their use
DE69819340T2 (de) Optisch reine camptothecinanaloge, optisch reines synthese-zwischenprodukt und verfahren zu ihrer herstellung
DE60102378T2 (de) Derivate des carbamates und thiocarbamates von podophyllotoxin, ihre herstellungsweise und pharmazeutische zusammensetzungen, die diese enthalten
US5883255A (en) Substituted indolizino 1,2-b!quinolinones
DE2632118A1 (de) Apovincaminolester und verfahren zu deren herstellung
DE60000125T2 (de) 7-Oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridincarboxylatderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition